These ASX shares could rise 35% to 40%

Analysts are tipping these shares to rocket from current levels. Let's see why they are so bullish on them.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you on the lookout for some big returns to supercharge your investment portfolio?

If you are, then it could be worth looking at the ASX shares listed below that have recently been tipped to rise by 35%+ by brokers.

Here's what you need to know about them:

Rising share price chart.

Image source: Getty Images

Johns Lyng Group Ltd (ASX: JLG)

Analysts at Morgans think that this insurance building and restoration services company's shares are undervalued right now. Especially given the announcement of a new acquisition, which the broker is positive on. It said:

We see Keystone as highly complementary to JLG's existing IB&RS business, which provides further scale to the group's domestic operations (particularly within QLD) as well as increased exposure to commercial and large loss claims work. Incorporating Keystone into our forecasts see our EBITDA upgraded by ~7% in FY25-27F, while increased level of debt to fund Keystone (and SSKB & Chill-rite), sees our EPS forecasts increase ~4%.

Morgans has an add rating and $5.10 price target on the ASX share. This implies potential upside of 39% for investors over the next 12 months.

Light & Wonder Inc (ASX: LNW)

This gaming developer's shares were sold off last week after being hit with an injunction from Aristocrat Leisure Limited (ASX: ALL). While this is disappointing, Goldman Sachs thinks the selling was overdone and believes the company will still outperform consensus estimates in FY 2025. It said:

This update is disappointing for LNW, given the early successes of Dragon Train in Australia and the US. However, while we take no view on the outcome of litigation, we believe the LNW share price move (-18%) post announcement appears overdone given: (1) Impact on near-term consensus earnings is likely to be limited, noting that the company reaffirmed its US$1.4bn FY25 target (+1% vs. VAe consensus of US$1,392), with Dragon Train estimated to account for less than 5% of this target (i.e. implying earnings were tracking ahead of LNW targets before this injunction).

Goldman has a buy rating and $190.00 price target on its shares. This suggests that upside of 41% is possible for investors from current levels.

Xero Ltd (ASX: XRO)

Goldman also continues to believe that Xero shares could deliver big returns for investors. In fact, last week, the broker lifted its price target even higher, predicting that it won't be long until its shares break through the $200 mark.

Its analysts are positive on the company due to its huge long-term growth opportunity. They said:

We see Xero as very well-placed to take advantage of the digitisation of SMBs globally, driven by compelling efficiency benefits and regulatory tailwinds, with >100mn SMBs worldwide representing a >NZ$100bn TAM. Given the company's pivot to profitable growth and corresponding faster earnings ramp, we see an attractive entry point into a global growth story with Xero our preferred large-cap technology name in ANZ – the stock is Buy rated.

Goldman has a buy rating and $201.00 price target on the company's shares. This implies potential upside of 35% for investors over the next 12 months.

Motley Fool contributor James Mickleboro has positions in Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Light & Wonder, and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Johns Lyng Group and Light & Wonder. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »